A six-member cyclic carbonate with protected functional groups was synthesized from tetramethylolmethane,benzaldehyde and ethyl choroformate.Coplymerization of（D,L-lactide） with cyclic carbonate was carried out thro...A six-member cyclic carbonate with protected functional groups was synthesized from tetramethylolmethane,benzaldehyde and ethyl choroformate.Coplymerization of（D,L-lactide） with cyclic carbonate was carried out through conventional ring-opening polymerization using Sn（Oct）2 as the catalyst.The effects of different catalysts,polymerization time and monomer-to-catalyst molar ratio on the molecular weight were investigated.The methods of removing protected groups were studied.Results showed the protected groups were effectively removed via catalytic hydrogenation.（Poly（D,L-lactide-co-cycliccarbonate）s） with hydroxyl pendant functional groups was obtained.展开更多
首次将聚(L-丙交酯-co-ε-己内酯)用于电纺防粘连膜的研究。通过对电纺条件的考查,发现在10k V电压、10%浓度、1m L/h注射速度下得到的电纺膜形貌最好,且纤维直径相对较细。聚(L-丙交酯-co-ε-己内酯)电纺膜尺寸稳定性良好,收缩率仅为2...首次将聚(L-丙交酯-co-ε-己内酯)用于电纺防粘连膜的研究。通过对电纺条件的考查,发现在10k V电压、10%浓度、1m L/h注射速度下得到的电纺膜形貌最好,且纤维直径相对较细。聚(L-丙交酯-co-ε-己内酯)电纺膜尺寸稳定性良好,收缩率仅为2%。电纺膜拉伸强度约为4MPa,断裂伸长率约为300%。经过14周的体外降解,电纺膜吸水率达到25%左右,质量损失约为1.3%,特性黏度从3.5 d L/g下降到0.5 d L/g;然而电纺膜拉伸强度和断裂伸长率保持了近8周时间,在第10周之后降幅明显。负载替硝唑药物的电纺膜24h内释放了80%的药物,展现了"突释"的药物释放行为。展开更多
以三(3,5-二叔丁基水杨醛缩苯乙胺)镧La(OPEBS)3为引发剂引发L-丙交酯(L-LA)和ε-己内酯(ε-CL)的共聚,可控合成嵌段共聚物.研究了单体加料顺序、投料比、单体与引发剂的摩尔比(M/I)及聚合温度对L-LA和ε-CL共聚的影响.由石油醚抽提纯...以三(3,5-二叔丁基水杨醛缩苯乙胺)镧La(OPEBS)3为引发剂引发L-丙交酯(L-LA)和ε-己内酯(ε-CL)的共聚,可控合成嵌段共聚物.研究了单体加料顺序、投料比、单体与引发剂的摩尔比(M/I)及聚合温度对L-LA和ε-CL共聚的影响.由石油醚抽提纯化的聚合物经GPC、1 H NMR和DSC分析,表明该共聚物为L-LA和ε-CL嵌段共聚物.展开更多
文摘A six-member cyclic carbonate with protected functional groups was synthesized from tetramethylolmethane,benzaldehyde and ethyl choroformate.Coplymerization of（D,L-lactide） with cyclic carbonate was carried out through conventional ring-opening polymerization using Sn（Oct）2 as the catalyst.The effects of different catalysts,polymerization time and monomer-to-catalyst molar ratio on the molecular weight were investigated.The methods of removing protected groups were studied.Results showed the protected groups were effectively removed via catalytic hydrogenation.（Poly（D,L-lactide-co-cycliccarbonate）s） with hydroxyl pendant functional groups was obtained.
文摘首次将聚(L-丙交酯-co-ε-己内酯)用于电纺防粘连膜的研究。通过对电纺条件的考查,发现在10k V电压、10%浓度、1m L/h注射速度下得到的电纺膜形貌最好,且纤维直径相对较细。聚(L-丙交酯-co-ε-己内酯)电纺膜尺寸稳定性良好,收缩率仅为2%。电纺膜拉伸强度约为4MPa,断裂伸长率约为300%。经过14周的体外降解,电纺膜吸水率达到25%左右,质量损失约为1.3%,特性黏度从3.5 d L/g下降到0.5 d L/g;然而电纺膜拉伸强度和断裂伸长率保持了近8周时间,在第10周之后降幅明显。负载替硝唑药物的电纺膜24h内释放了80%的药物,展现了"突释"的药物释放行为。
文摘以三(3,5-二叔丁基水杨醛缩苯乙胺)镧La(OPEBS)3为引发剂引发L-丙交酯(L-LA)和ε-己内酯(ε-CL)的共聚,可控合成嵌段共聚物.研究了单体加料顺序、投料比、单体与引发剂的摩尔比(M/I)及聚合温度对L-LA和ε-CL共聚的影响.由石油醚抽提纯化的聚合物经GPC、1 H NMR和DSC分析,表明该共聚物为L-LA和ε-CL嵌段共聚物.
